Overview
Simrit Parmar is a Hematologist Oncology provider in Houston, Texas. Dr. Parmar has been practicing medicine for over 20 years and is rated as an Experienced provider by MediFind in the treatment of Waldenstrom Macroglobulinemia. Her top areas of expertise are Multiple Myeloma, Primary Amyloidosis, Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Bone Marrow Aspiration.
Her clinical research consists of co-authoring 113 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
MD Anderson
Robert Orlowski is a Hematologist Oncology specialist and an Oncologist in Houston, Texas. Dr. Orlowski is rated as an Elite provider by MediFind in the treatment of Waldenstrom Macroglobulinemia. His top areas of expertise are Multiple Myeloma, Plasmacytoma, Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.
MD Anderson
Sheeba Thomas is an Oncologist and a Hematologist Oncology provider in Houston, Texas. Dr. Thomas is rated as a Distinguished provider by MediFind in the treatment of Waldenstrom Macroglobulinemia. Her top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Waldenstrom Macroglobulinemia, Relapsed Refractory Multiple Myeloma (RRMM), and Bone Marrow Aspiration.
Jatin Shah is a Hematologist Oncology provider in Houston, Texas. Dr. Shah is rated as a Distinguished provider by MediFind in the treatment of Waldenstrom Macroglobulinemia. His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Multiple MyelomaDr. Parmar isElite. Learn about Multiple Myeloma.
- Distinguished
- Bone Marrow TransplantDr. Parmar isDistinguished. Learn about Bone Marrow Transplant.
- Graft Versus Host Disease (GvHD)Dr. Parmar isDistinguished. Learn about Graft Versus Host Disease (GvHD).
- Primary AmyloidosisDr. Parmar isDistinguished. Learn about Primary Amyloidosis.
- Advanced
- Acute Myeloid Leukemia (AML)Dr. Parmar isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Hodgkin LymphomaDr. Parmar isAdvanced. Learn about Hodgkin Lymphoma.
- Large-Cell Immunoblastic LymphomaDr. Parmar isAdvanced. Learn about Large-Cell Immunoblastic Lymphoma.
- LeukemiaDr. Parmar isAdvanced. Learn about Leukemia.
- Mantle Cell Lymphoma (MCL)Dr. Parmar isAdvanced. Learn about Mantle Cell Lymphoma (MCL).
- Experienced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Anaplastic Large Cell LymphomaDr. Parmar isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- AnemiaDr. Parmar isExperienced. Learn about Anemia.
- Aplastic AnemiaDr. Parmar isExperienced. Learn about Aplastic Anemia.
- B-Cell LymphomaDr. Parmar isExperienced. Learn about B-Cell Lymphoma.